Safety and efficacy of everolimus with exemestane vs. Exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2

by Kathleen I. Pritchard, Howard A. Burris, Yoshinori Ito, Hope S. Rugo, Shaker Dakhil, Gabriel N. Hortobagyi, Mario Campone, Tibor Csöszi, José Baselga, Puttisak Puttawibul, Martine Piccart, Daniel Heng, Shinzaburo Noguchi, Vichien Srimuninnimit, Hugues Bourgeois, Antonio Gonzalez Martin, Karen Osborne, Ashok Panneerselvam, Tetiana Taran, Tarek Sahmoud, Michael Gnant
Published 2018